Multi-Omics Approaches to Validating Rasayana: Genomics, Proteomics, and Metabolomics

Rasayana is the rejuvenative branch of Ayurveda concerned with longevity, strength, memory, resilience, nourishment, complexion, voice, sensory clarity, and resistance to illness. These are broad, system-wide outcomes rather than single-target effects, so the most suitable modern research tools are those that can observe many biological layers at once.

Multi-omics research combines high-throughput approaches such as genomics, transcriptomics, proteomics, metabolomics, and sometimes microbiome profiling. For rasayana research, this approach is valuable because it can map how a herb, formulation, diet, or regimen influences gene expression, protein pathways, metabolites, immune signals, oxidative stress, and tissue-level physiology together rather than in isolation.

Why Multi-Omics Fits Rasayana

The classical logic of rasayana is closer to systems biology than to a one-drug, one-target pharmacology model. A rasayana formulation may contain many botanicals, minerals, fats, sugars, and processing steps, and its intended effect is not merely symptom suppression but support of dhatu quality, agni, srotas, bala, medha, and ojas.

• Genomics can help examine inherited differences, including whether prakriti-based stratification corresponds to biological variation.
• Transcriptomics can reveal changes in gene expression after exposure to a rasayana herb or formulation.
• Proteomics and protein-level assays can track stress proteins, enzymes, receptors, inflammatory mediators, and repair pathways.
• Metabolomics can capture changes in amino acids, lipids, energy metabolites, oxidative markers, and small molecules closest to functional physiology.
• Integrated multi-omics can connect these layers into a systems-level map that is more suitable for complex Ayurvedic interventions.

Charaka describes rasayana as that which supports long life, memory, intellect, freedom from disease, youthful qualities, complexion, voice, strength of body, and strength of the senses. These classical outcomes cannot be reduced to one biomarker. They require a research design that can follow coordinated changes across metabolism, immunity, tissue function, and cognition.

Classical Grounding: Rasayana as a Tissue-Level Strategy

In classical Ayurveda, rasayana is not only a category of herbs. It includes diet, formulations, cleansing preparation when appropriate, daily conduct, and individualized administration. Its central aim is to improve the quality of nourishment and tissue formation so that the body maintains strength, clarity, and resistance over time.

This makes dhatu quality, agni, srotas, and ojas important interpretive categories for modern research. A contemporary protocol can translate these into measurable domains such as nutritional status, inflammatory balance, oxidative stress, mitochondrial function, immune markers, cognitive testing, sleep, physical performance, and metabolomic signatures.

Genomics and Ayurgenomics

Ayurgenomics is one of the most important bridges between Ayurveda and omics science. It examines whether Ayurvedic classifications such as prakriti correspond to measurable genetic, gene-expression, biochemical, and metabolic differences. This is especially relevant for rasayana because rejuvenative interventions are traditionally individualized.

Published work from Indian Ayurgenomics initiatives has examined prakriti in relation to genome-wide markers, gene-expression differences, hypoxia-response biology, metabolic traits, and plasma metabolomic patterns. This does not make prakriti a substitute for clinical diagnosis, but it gives researchers a practical way to stratify participants before testing rasayana interventions.

For rasayana trials, this matters because two people may respond differently to the same herb or formulation. Genomic and prakriti-aware stratification can help identify responders, non-responders, safety signals, and subgroup-specific metabolic patterns that would be blurred in an unstratified trial.

Transcriptomic Signals from Rasayana-Associated Botanicals

Transcriptomics is useful for rasayana research because it shows how cells alter gene expression after exposure to a botanical extract or formulation. These data can help identify whether a candidate rasayana influences pathways related to stress response, inflammation, neural signaling, cell survival, transport, or metabolism.

Ashwagandha (Withania somnifera)

Ashwagandha is widely used in Ayurveda as a strengthening and restorative herb. Cell-based work with Withania somnifera extracts has documented effects on neuronal and glial models, including changes in markers related to differentiation, stress proteins, extracellular matrix modulation, and cellular resilience.

In neuroblastoma and glioma cell models, ashwagandha water extract has been examined for protection against glutamate-induced excitotoxicity and for effects on neuronal differentiation markers. Reported protein and pathway markers include HSP70, mortalin, NCAM, PSA-NCAM, neurofilament proteins, matrix metalloproteinases, Akt phosphorylation, cyclin D1, and Bcl-xl. These are not whole-human rasayana outcomes, but they provide mechanistic entry points for medhya and balya research.

More recent gene-expression work with Withania somnifera root preparations has examined pathways connected with oxidative response, cellular stress adaptation, inflammation, and neuronal protection. For rasayana validation, the most responsible use of these findings is to design better human trials with transcriptomic endpoints paired with clinical measures such as sleep, stress, fatigue, cognition, inflammatory markers, and safety labs.

Brahmi and Bacopa monnieri

Bacopa monnieri is widely used as Brahmi in modern Ayurveda and is commonly associated with medhya effects. Classical Charaka descriptions of medhya rasayana specifically list Mandukaparni, Yashtimadhu, Guduchi, and Shankhapushpi; modern regional practice also commonly uses Bacopa monnieri under the name Brahmi.

RNA-sequencing work in differentiated SH-SY5Y human neuroblastoma cells found that Bacopa monnieri extract altered gene-expression patterns related to mRNA translation regulation, transmembrane transport, protein misfolding, and oxidative stress response. In the same experimental context, Bacopa exposure was also examined against hydrogen-peroxide-induced toxicity. These findings fit the research question of how medhya herbs may influence neuronal stress and cellular adaptation, while still requiring clinical correlation for memory and cognition claims.

Proteomics and Protein-Level Readouts

Proteomics and targeted protein assays are important because gene-expression shifts do not always translate into functional protein changes. Rasayana research benefits from measuring enzymes, inflammatory proteins, heat-shock proteins, apoptotic markers, mitochondrial proteins, immune mediators, and tissue-repair markers alongside transcriptomic and metabolomic data.

Ashwagandha Protein Endpoints

Ashwagandha cell studies have used protein markers such as HSP70, mortalin, NCAM, PSA-NCAM, neurofilament proteins, MMP-2, MMP-9, cyclin D1, Bcl-xl, and Akt phosphorylation to examine stress response, differentiation, proliferation, and cellular survival. These protein endpoints are useful because they help connect the traditional categories of bala, medha, and rasayana support with measurable cellular processes.

Future proteomic work on ashwagandha should move beyond single-cell models and include human samples, standardized extracts, batch phytochemical fingerprints, clinically meaningful endpoints, and safety monitoring. A strong design would pair proteomic panels with sleep scores, fatigue scores, inflammatory markers, liver enzymes, thyroid-related safety markers when relevant, and participant stratification by constitution and baseline health status.

Triphala as a Multi-Component Formulation

Triphala is a classical three-fruit formulation composed of Haritaki, Bibhitaki, and Amalaki. Although many modern experiments focus on isolated disease models, Triphala is especially relevant to systems-style research because it combines multiple fruits rich in polyphenols, tannins, and other small molecules.

In human colon cancer cell and colon cancer stem-cell models, methanolic Triphala extract has been evaluated with phytochemical analysis, antioxidant testing, proliferation assays, apoptosis markers, and protein-level Western blot endpoints. Reported molecular markers include c-Myc, cyclin D1, Bax, Bcl-2, and cleaved PARP. For rasayana research, this demonstrates how a classical formulation can be profiled through chemical fingerprints and multi-marker protein panels rather than one isolated constituent.

For more on Triphala’s gut-focused research context, see our article on How Triphala Reshapes Your Gut.

Metabolomics: The Biochemical Fingerprint

Metabolomics is especially well suited to rasayana because it captures small-molecule changes close to the functional state of the body. While genomics indicates inherited potential and transcriptomics indicates cellular messaging, metabolomics reflects ongoing shifts in energy metabolism, amino acid handling, lipid pathways, oxidative balance, and gut-derived metabolites.

Withania-Bacopa Metabolomic Profiling

A recent NMR-based metabolomic investigation examined a combined Withania somnifera and Bacopa monnieri formulation in SH-SY5Y human neuroblastoma cells. The formulation was chemically characterized by UHPLC-HRMS/MS and then evaluated through endometabolomic and exometabolomic profiling.

The metabolomic analysis identified changes in amino acid pathways, neurotransmission-related metabolites, energy-metabolism signals, and oxidative-stress-related biochemical patterns. These findings are useful for rasayana research because they show how a multi-herb preparation can be mapped as a biochemical network rather than as a single isolated molecule.

Prakriti and Metabolomic Stratification

Metabolomic work on prakriti phenotypes has reported differences in plasma metabolic pathways among constitution groups. This supports a practical research principle: rasayana trials should record baseline constitution, diet, digestive status, sleep, age, sex, and metabolic health because these may influence metabolomic response.

A rasayana metabolomics trial that ignores baseline diversity may miss the very individuality that Ayurveda considers central. A better design would compare pre-treatment and post-treatment metabolomes within each participant, then examine whether response clusters align with prakriti, age, metabolic state, and clinical outcomes.

Polyherbal Rasayana: Chyawanprash as a Formulation Case

Chyawanprash is one of the best-known classical rasayana formulations, traditionally centered on Amalaki and prepared with many supporting ingredients. Modern reviews describe it as a polyherbal health supplement in which Amla is the prime ingredient and numerous additional botanicals contribute to the final formulation.

For multi-omics research, Chyawanprash should be studied as a whole formulation, not only as Amalaki. The classical concept of yoga, or formulation design, implies that the combined preparation may have a distinct biological profile. A suitable omics study would therefore compare the complete formulation with key ingredients, control preparations, and matched dietary controls.

Clinical and experimental work on Chyawanprash has focused mainly on immunity-related parameters, general health, infection-related symptom patterns, and inflammatory models. These provide useful endpoints for future multi-omics studies: immune-cell transcriptomics, cytokine panels, plasma metabolomics, gut microbiome profiling, oxidative markers, and clinical records of seasonal respiratory symptoms.

Amalaki Rasayana and Telomerase Research

Amalaki is central to many rasayana preparations and is also used as a rasayana in its own right. Human work on Amalaki Rasayana has examined telomerase activity and telomere length in peripheral blood mononuclear cells from healthy aged adults.

In that trial context, telomerase activity increased after Amalaki Rasayana administration, while telomere length did not show a discernible increase over the observation period. This is an important example of how rasayana claims can be examined carefully: a molecular aging-related marker may move without automatically proving lifespan extension or broad anti-aging benefit.

Integrated Multi-Omics: The Systems Biology Approach

The strongest rasayana research design is not a single omics platform but an integrated model. A well-built study can combine baseline prakriti assessment, standardized formulation chemistry, transcriptomics, proteomics, metabolomics, microbiome profiling, clinical endpoints, and safety labs.

For example, a Chyawanprash or Amalaki Rasayana trial could collect blood, stool, diet records, sleep data, symptom logs, and validated quality-of-life measures at baseline and follow-up. The omics layers could then be integrated to see whether immune, metabolic, antioxidant, and microbial shifts move together with clinically meaningful outcomes.

Bioinformatics platforms such as MetaboAnalyst, iDEP, and MOFA-family tools can support pathway analysis, transcriptomic interpretation, metabolomic integration, and multi-omics factor analysis. These tools are especially useful when the research question is not one isolated molecule but a coordinated biological signature.

Methodological Requirements for Rasayana Omics Studies

Rasayana research needs stricter methodology than ordinary supplement screening because the interventions are complex and traditionally individualized. Without standardization, stratification, and clinical endpoints, omics data can become large but difficult to interpret.

What the Current Evidence Supports

The most useful conclusion from current omics-oriented work is that rasayana-associated herbs and formulations can be studied as multi-target biological interventions. The strongest evidence is still pathway-mapping and mechanism-building rather than definitive clinical proof of classical outcomes.

1. Systems-level mapping is appropriate: Rasayana interventions are complex, and multi-omics can capture broad molecular patterns more effectively than a single biomarker.
2. Prakriti can guide stratification: Ayurgenomics work supports the idea that constitution-based grouping can be explored biologically and may improve trial design.
3. Medhya herbs can be examined mechanistically: Ashwagandha and Bacopa research provides cellular and molecular endpoints relevant to neuronal stress, differentiation, oxidative response, and metabolic adaptation.
4. Formulation-level research is necessary: Chyawanprash and Triphala should be profiled as complete formulations because their biological signatures may differ from isolated ingredients.
5. Metabolomics is especially valuable: Metabolite patterns can connect rasayana theory with measurable changes in energy metabolism, amino acid pathways, oxidative balance, and immune-metabolic function.

Our article on Nrf2 Pathway Activation by Ayurvedic Herbs examines one specific antioxidant-response pathway that can be integrated into broader rasayana omics research.

Boundaries of Interpretation

Omics can reveal biological signatures, but rasayana validation still requires careful clinical research. Cell-line experiments, animal models, protein panels, and metabolomic shifts are useful for mechanism building; they should be connected to human outcomes before making strong claims about longevity, disease prevention, immunity, or cognitive improvement.

• Lifespan: Aging-related markers such as telomerase activity, oxidative stress, and mitochondrial metabolism are not the same as demonstrated human lifespan extension.
• Clinical outcomes: A transcriptomic or metabolomic change should be paired with validated clinical endpoints.
• Dose and duration: Rasayana protocols may involve specific preparation, diet, timing, and duration; short supplement trials may not represent the full classical method.
• Individualization: Constitution, digestion, age, illness, medication use, and lifestyle can influence response and safety.
• Quality control: The same classical name can refer to products of very different quality, composition, and potency.

Future Directions

The next phase of rasayana research should combine classical precision with modern measurement. The goal should not be to force Ayurveda into a single-target drug model, but to test its systems-level claims with rigorous, transparent, reproducible tools.

• Longitudinal multi-omics: Track changes over weeks and months to see how rasayana responses develop over time.
• Single-cell omics: Identify which immune, neural, or metabolic cell populations respond most strongly.
• Microbiome integration: Study how formulations such as Triphala and Chyawanprash interact with gut microbial metabolism.
• Network pharmacology: Combine phytochemical data with pathway modeling to identify plausible multi-target effects.
• Prakriti-stratified trials: Test whether Ayurvedic constitution improves prediction of response and safety.
• Open data and batch reporting: Publish omics datasets with formulation fingerprints so that results can be compared across studies.

Perspective for the Field

Multi-omics gives rasayana research a practical way to examine what classical Ayurveda described in qualitative language: systemic nourishment, resilience, strength, clarity, and balanced tissue function. The best use of these tools is neither blind acceptance nor dismissal, but careful mapping of what changes, in whom, at what dose, for how long, and with what clinical meaning.

When used responsibly, genomics, transcriptomics, proteomics, metabolomics, and systems biology can help build a more mature evidence base for rasayana. They can also protect the field from overstatement by separating molecular plausibility from clinical proof. This balanced approach respects both the classical tradition and the standards needed for modern healthcare research.

Medical Disclaimer: This article is for educational purposes only. Rasayana herbs and formulations should be used under the guidance of a qualified Ayurvedic practitioner and, when relevant, a licensed healthcare provider. Do not use rasayana preparations as a substitute for prescribed treatment. Consult your healthcare provider before starting any supplement, especially if you are pregnant, have a medical condition, have liver, kidney, thyroid, autoimmune, or metabolic concerns, or take prescription medicines.

References

1. Charaka Samhita — Rasayana Adhyaya
2. Applications of multi-omics analysis in human diseases (2023), PubMed Central
3. Systems Biology and Multi-Omics Integration: Viewpoints from the Metabolomics Research Community (2019), PubMed Central
4. The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer (2022), PubMed Central
5. Nature (nature.com)
6. Csir (csir.res.in)
7. Combined genetic effects of EGLN1 and VWF modulate thrombotic outcome in hypoxia revealed by Ayurgenomics approach (2015), PubMed
8. Prakriti and its associations with metabolism, chronic diseases, and genotypes: Possibilities of new born screening and a lifetime of personalized prevention (2014), PubMed Central
9. Plasma metabolomics reveal the correlation of metabolic pathways and Prakritis of humans (2018), PubMed Central
10. Nootropic herbs (Medhya Rasayana) in Ayurveda: An update (2012), PubMed Central
11. Journals (journals.plos.org)
12. Journals (journals.plos.org)
13. Journals (journals.plos.org)
14. Frontiersin (frontiersin.org)
15. Triphala Extract Suppresses Proliferation and Induces Apoptosis in Human Colon Cancer Stem Cells via Suppressing c-Myc/Cyclin D1 and Elevation of Bax/Bcl-2 Ratio (2015), PubMed Central
16. Mdpi (mdpi.com)
17. Chyawanprash: A Traditional Indian Bioactive Health Supplement (2019), PubMed Central
18. Evaluation of Cyavanaprāśa on Health and Immunity related Parameters in Healthy Children: A Two Arm, Randomized, Open Labeled, Prospective, Multicenter, Clinical Study (2017), PubMed Central
19. Chyawanprash, An Ancient Indian Ayurvedic Medicinal Food, Regulates Immune Response in Zebrafish Model of Inflammation by Moderating Inflammatory Biomarkers (2021), PubMed Central
20. Influence of Amalaki Rasayana on telomerase activity and telomere length in human blood mononuclear cells (2017), PubMed
21. Metaboanalyst (metaboanalyst.ca)
22. iDEP Web Application for RNA-Seq Data Analysis (2021), PubMed
23. Multi-Omics Factor Analysis-a framework for unsupervised integration of multi-omics data sets (2018), PubMed Central
24. NIH Office of Dietary Supplements